Informa plc (LON:INF) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Informa plc (LON:INF) have been assigned an average recommendation of “Buy” from the six brokerages that are covering the stock, MarketBeat reports. Six analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have issued ratings on the stock in the last year is GBX 1,135.

Several equities research analysts have issued reports on INF shares. JPMorgan Chase & Co. cut their target price on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research note on Thursday, July 2nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,140 price target on shares of Informa in a research note on Friday, July 31st. Citigroup raised their price objective on Informa from GBX 990 to GBX 1,090 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. Finally, Berenberg Bank raised their price objective on Informa from GBX 965 to GBX 1,040 and gave the stock a “buy” rating in a research report on Friday, July 31st.

Informa Stock Performance

Informa stock opened at GBX 874.60 on Friday. The firm has a 50 day simple moving average of GBX 895.75 and a 200-day simple moving average of GBX 842. The stock has a market cap of £10.93 billion, a price-to-earnings ratio of 51.15, a price-to-earnings-growth ratio of 0.75 and a beta of 0.68. The company has a debt-to-equity ratio of 64.99, a current ratio of 0.55 and a quick ratio of 1.70. Informa has a 1-year low of GBX 719 and a 1-year high of GBX 1,000.

Informa (LON:INF) last released its quarterly earnings results on Thursday, July 30th. The company reported GBX 26.70 EPS for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. On average, analysts expect that Informa will post 59.3240265 EPS for the current year.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.